These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


147 related items for PubMed ID: 9065275

  • 21. Intravesical instillations with bacillus calmette-guérin for the treatment of carcinoma in situ involving prostatic ducts.
    Palou Redorta J, Schatteman P, Huguet Pérez J, Segarra Tomás J, Rosales Bordes A, Algaba F, Villavicencio Mavrich H.
    Eur Urol; 2006 May; 49(5):834-8; discussion 838. PubMed ID: 16426729
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Investigation of granulomatous prostatitis incidence following intravesical BCG therapy.
    Balasar M, Doğan M, Kandemir A, Taskapu HH, Cicekci F, Toy H, Gurbuz R.
    Int J Clin Exp Med; 2014 May; 7(6):1554-7. PubMed ID: 25035779
    [Abstract] [Full Text] [Related]

  • 24. Self-report of prostatitis and its risk factors in a random sample of middle-aged men.
    Rothman I, Stanford JL, Kuniyuki A, Berger RE.
    Urology; 2004 Nov; 64(5):876-9; discussion 879-80. PubMed ID: 15533468
    [Abstract] [Full Text] [Related]

  • 25. [Granulomatous Prostatitis : Three Cases Report].
    Ikeda J, Murakami S, Kawa G, Shibuya S.
    Hinyokika Kiyo; 2019 Mar; 65(3):69-73. PubMed ID: 31067846
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Prostatitis syndromes: pathophysiology, differential diagnosis, and treatment.
    Krieger JN.
    Sex Transm Dis; 1984 Mar; 11(2):100-12. PubMed ID: 6379919
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Mycobacterium abscessus granulomatous prostatitis.
    Chuang AY, Tsou MH, Chang SJ, Yang LY, Shih CC, Tsai MP, Chen YL, Liu TM, Liao CH, Hsueh PR.
    Am J Surg Pathol; 2012 Mar; 36(3):418-22. PubMed ID: 22261705
    [Abstract] [Full Text] [Related]

  • 31. Incidence and clinical characteristics of National Institutes of Health type III prostatitis in the community.
    Clemens JQ, Meenan RT, O'Keeffe Rosetti MC, Gao SY, Calhoun EA.
    J Urol; 2005 Dec; 174(6):2319-22. PubMed ID: 16280832
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Impact of prostatic benign hyperplasia and prostatic inflammation on the increase of prostate specific antigen levels].
    Ferrero Doria R, Pérez Flores D, Terrer Artes C, Guzmán Martínez-Valls PL, Morga Egea JP, Tomás Ros M, Rico Galiano JL, Sempere Gutiérrez A, Fontana Compiano LO.
    Actas Urol Esp; 1997 Feb; 21(2):100-4. PubMed ID: 9214204
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Granulomatous prostatitis due to Cryptococcus neoformans: diagnostic usefulness of special stains and molecular analysis of 18S rDNA.
    Wada R, Nakano N, Yajima N, Yoneyama T, Wakasaya Y, Murakami C, Yamato K, Yagihashi S.
    Prostate Cancer Prostatic Dis; 2008 Feb; 11(2):203-6. PubMed ID: 18180804
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Aspecific granulomatous prostatitis. Our experience].
    Ghiron P, Dato I, Giudici M.
    Minerva Med; 1987 Nov 15; 78(21):1617-20. PubMed ID: 3683959
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.